When we compared patients and controls after anti-BCR stimulation, AP-CVID CD27– B cells induced lower Bcl-XL and Bax levels and CD27– B cells from the remaining CVID patients induced lower Bcl-2 and Bcl-XL levels (Fig. 5a). This evidence concerns the gene BCL2 and common variable immunodeficiency.